Carroll Financial Associates’s St Jude Medical STJ Stock Holding History

Carroll Financial Associates’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13	Closed	-$1K	–	1287
2016 Q4	$1K	Hold	13	–	–	﹤0.01%	1126
2016 Q3	$1K	Hold	13	–	–	﹤0.01%	1135
2016 Q2	$1K	Sell	13 -8	-38%	-$570	﹤0.01%	1121
2016 Q1	$1K	Hold	21	–	–	﹤0.01%	1107
2015 Q4	$1K	Hold	21	–	–	﹤0.01%	1077
2015 Q3	$1K	Buy	+21	New	+$1.5K	﹤0.01%	1058

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Carroll Financial Associates's STJ Position: Q1 2017 in Review

Carroll Financial Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 13 shares — an estimated $1K sold.

Carroll Financial Associates first reported a position in STJ in Q3 2015 and held it in 6 quarters. The position peaked at $1K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Carroll Financial Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Carroll Financial Associates sold 13 St Jude Medical shares in Q1 2017, an estimated $1K.
Carroll Financial Associates first reported a position in St Jude Medical in Q3 2015 and held it in 6 quarters.
Carroll Financial Associates's St Jude Medical position peaked at $1K in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Carroll Financial Associates's 13F filing for Q1 2017, filed 11 Apr 2017.